Author: devcuration

Some companies chase the AI moment. Others quietly wire the economy underneath it. Synergetics.ai sits firmly in the second camp, building the pipes, rails, and toll booths for a future where software does not just talk, it negotiates, settles, and earns. This week, that vision picked up real momentum with a strategic Seed token investment from Taisu Ventures, focused on accelerating the SGTX token launch and expanding the Agent Economy. Founded in Feb 2024 and rebranded from UnifyGPT Inc. in July, Synergetics.ai is not shipping another chatbot with a fresh coat of UX polish. The company is constructing infrastructure for…

Databricks just closed a Series L north of $4B, announced Dec 16, 2025, and that number is supposed to feel loud. It should. This is what happens when a company built by the original architects of Apache Spark decides it is done explaining itself. Founded in 2013 by Ali Ghodsi, Matei Zaharia, Reynold Xin, Patrick Wendell, Ion Stoica, Andy Konwinski, and Arsalan Tavakoli-Shiraji, Databricks did not crawl out of a pitch deck. It came out of UC Berkeley AMPLab with a research paper, an open source engine, and a very clear opinion about how data was supposed to move. The…

Cold chain rarely gets applause. It hums in the background, ignored, until it fails and suddenly everyone becomes a philosopher about risk, waste, and why lifesaving medicine should not feel like a coin toss. Ember LifeSciences lives in that narrow gap between silence and consequence, and the market just put weight behind it with a $16.5M Series A led by Sea Court Capital, joined by Cardinal Health, returning strategic investor Carrier Ventures, and Mike Pompeo. Ember LifeSciences spun out of Ember Technologies in 2022, taking the same thermal discipline that kept coffee at the right temp and pointing it at…

Walk into a grocery store and notice where real decisions get made. Not on a phone. Not in a slide deck. They happen under fluorescent lights, five feet from the shelf, with a cart wheel squeaking and a clock ticking in someone’s head. Looma lives exactly there, and that is the whole point. Founded Jan 2015 and HQ in Durham, NC, Looma built an enterprise-grade in-store retail media platform that does not shout ads. It tells stories, teaches shoppers, and sharpens the moment of choice. Cole Johnson saw that gap early, long before retail media became a buzzword, and decided…

Fake users used to be a rounding error. An annoyance. Something teams patched with CAPTCHA, crossed fingers, and a quiet hope. Then AI showed up with unlimited stamina, zero ethics, and a talent for scale. That is the environment Verisoul was born into in Austin, TX, not as a feature, not as a tool, but as a response from people who had already watched trust collapse in slow motion. Henry LeGard did not stumble into this problem. Bain & Company teaches you how systems fail politely before they fail publicly. Neustar and TransUnion teach you how fraud evolves faster than…

In 2017, four people who already survived one ad tech war together decided they were not done yet. Fluency came out of Burlington, Vermont, not chasing noise but fixing a problem that had been irritating Mike Lane, Eric Mayhew, Brian McVey, and Scott Gale since their Dealer.com days. Back then, scale was pain and manual work quietly ate margin. Complexity multiplied while humans clicked themselves into exhaustion. So they built the system they wished existed. Years later, that instinct looks expensive in exactly the right way. Fast forward to December 2025 and Fluency locks in a $40M Series A led…

Some companies raise capital. Others raise the temperature of an entire industry. Culture Biosciences just closed a Series C, undisclosed but loud enough to echo through South San Francisco and every cleanroom still pretending spreadsheets count as infrastructure. Northpond Ventures, Synthesis Capital, S32, and Cultivian Sandbox all came back for another lap. That is not nostalgia. That is conviction. Smart money does not re-up unless the data keeps punching above its weight. Culture Biosciences started in 2016 when Will Patrick and Matt Ball spotted a mismatch that felt almost insulting. Software scaled at the speed of thought. Bioprocess development crawled…

Money shows up when the mess gets expensive enough that ignoring it becomes malpractice. In semiconductors, the mess is quiet, global, and stacked neatly on shelves. Perfectly good chips written off because forecasts flinched, designs shifted, or someone ordered too much and kept walking. About $15B a year in ghost inventory. Mobius Materials decided that pretending this is normal is the real defect. Mobius Materials just raised $3M in Series Seed funding, led by Spero Ventures with participation from Outsiders Fund and REFASHIOND Ventures: The Industrial Transformation Fund. Richmond, Virginia is now home to a marketplace that treats hardware like…

There are healthcare rollups that chase scale, and then there are platforms that actually understand anatomy, incentives, and gravity. Curalta Foot & Ankle just secured a growth investment led by SharpVue Capital, and this is not about fresh dollars chasing logos. This is pressure applied precisely where outcomes, ops, and patient trust intersect. Foot and ankle care sits at the crossroads of chronic disease, mobility, aging populations, and quality of life. Ignore it and everything else limps. Founded in 2021 by David Del Vecchio and Vincent Giacalone, DPM, FACFAS, Curalta Foot & Ankle went after a podiatry market that had…

In 2014, a new parent stared into a crib and realized the video feed was lying by omission. You could see a baby, sure, but you could not measure sleep, breathing, growth, or the patterns that matter when the house goes quiet at 2:17 a.m. That gap became Nanit, founded by Dr. Assaf Glazer, Tor Ivry, and Andrew Berman, built on the idea that parenting deserves data with a pulse, not just pixels. NYC for the business brain, Tel Aviv for the computer vision muscle, and a mission born equal parts love, science, and frustration. That origin story aged well.…